• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A novel method for gene expression mapping of metastatic competence in human bladder cancer.一种用于绘制人类膀胱癌转移能力基因表达图谱的新方法。
Neoplasia. 2006 Mar;8(3):181-9. doi: 10.1593/neo.05727.
2
Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?通过使用阵列比较基因组杂交分析,膀胱腺癌能否与血吸虫病相关的膀胱癌区分开来?
Cancer Genet Cytogenet. 2007 Sep;177(2):153-7. doi: 10.1016/j.cancergencyto.2007.06.017.
3
Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.通过光谱核型分析、比较基因组杂交以及一种新的定位表达谱分析方法,对具有不同致瘤和转移潜能的谱系相关人膀胱癌细胞系进行功能基因组比较。
Cancer Res. 2002 Dec 1;62(23):6981-9.
4
Patterns of chromosomal imbalances in muscle invasive bladder cancer.肌层浸润性膀胱癌的染色体失衡模式
Int J Oncol. 2000 Nov;17(5):1025-9. doi: 10.3892/ijo.17.5.1025.
5
Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.
Cancer Genet Cytogenet. 2007 Aug;177(1):16-9. doi: 10.1016/j.cancergencyto.2007.04.010.
6
Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.非侵袭性和侵袭性人类移行细胞癌配对样本的基因拷贝数、转录本及蛋白质水平的全基因组研究。
Mol Cell Proteomics. 2002 Jan;1(1):37-45. doi: 10.1074/mcp.m100019-mcp200.
7
Identification of genes correlated with early-stage bladder cancer progression.鉴定与早期膀胱癌进展相关的基因。
Cancer Prev Res (Phila). 2010 Jun;3(6):776-86. doi: 10.1158/1940-6207.CAPR-09-0189. Epub 2010 May 25.
8
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.综合基因组和基因表达谱分析确定了尿路上皮癌中的两个主要基因组回路。
PLoS One. 2012;7(6):e38863. doi: 10.1371/journal.pone.0038863. Epub 2012 Jun 7.
9
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.鉴别膀胱表浅性、肌层浸润性和转移性移行细胞癌:利用基因表达谱的cDNA阵列分析
Clin Cancer Res. 2004 May 15;10(10):3410-21. doi: 10.1158/1078-0432.CCR-03-0134.
10
bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.bc10:一种新型的与人类膀胱癌相关的蛋白质,其基因组结构保守,在浸润性癌中表达下调。
Int J Cancer. 2002 Apr 1;98(4):539-46. doi: 10.1002/ijc.10244.

引用本文的文献

1
Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.皮肤狼疮的皮肤和外周血转录组数据分析揭示了 CCR2-一个新的潜在治疗靶点。
Front Immunol. 2019 Mar 29;10:640. doi: 10.3389/fimmu.2019.00640. eCollection 2019.
2
Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.白癜风血液转录组学为疾病机制提供了新见解,并确定了潜在的新型治疗靶点。
BMC Genomics. 2017 Jan 28;18(1):109. doi: 10.1186/s12864-017-3510-3.
3
Pharmacogenomics in bladder cancer.膀胱癌的药物基因组学。
Urol Oncol. 2014 Jan;32(1):16-22. doi: 10.1016/j.urolonc.2013.09.007.
4
Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.利用尿 DNA 的比较基因组杂交 (CGH) 阵列鉴定膀胱癌中的前折叠蛋白扩增 (1q23.3-q24.1)。
J Transl Med. 2013 Aug 1;11:182. doi: 10.1186/1479-5876-11-182.
5
Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy.一致性基因表达特征可预测接受全身治疗的癌症患者的临床结局。
Cancer Res. 2009 Nov 1;69(21):8302-9. doi: 10.1158/0008-5472.CAN-09-0798. Epub 2009 Oct 20.
6
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.分析膀胱癌器官部位特异性转移可确定LAMC2为血行播散的新型生物标志物。
Am J Pathol. 2009 Feb;174(2):371-9. doi: 10.2353/ajpath.2009.080538. Epub 2009 Jan 15.
7
Neoplasia: the second decade.肿瘤形成:第二个十年。
Neoplasia. 2008 Dec;10(12):1314-24. doi: 10.1593/neo.81372.
8
Molecular credentialing of rodent bladder carcinogenesis models.啮齿动物膀胱癌发生模型的分子鉴定
Neoplasia. 2008 Aug;10(8):838-46. doi: 10.1593/neo.08432.
9
[Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series].[膀胱癌细胞系作为膀胱癌病理生物学模型。文献综述及新进展系列的建立]
Urologe A. 2008 Jun;47(6):724-34. doi: 10.1007/s00120-008-1687-4.
10
Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations.膀胱肿瘤中纤维母细胞生长因子受体3突变与染色体改变的低频率相关。
Neoplasia. 2008 Jan;10(1):1-7. doi: 10.1593/neo.07178.

本文引用的文献

1
Profiling the evolution of human metastatic bladder cancer.剖析人类转移性膀胱癌的演变过程。
Cancer Res. 2004 Nov 1;64(21):7813-21. doi: 10.1158/0008-5472.CAN-04-0826.
2
Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.UbcH10泛素缀合酶在不同解剖学来源的人类癌症中的过表达、基因组扩增及抑制其表达的治疗潜力
Oncogene. 2004 Aug 26;23(39):6621-9. doi: 10.1038/sj.onc.1207861.
3
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.鉴别膀胱表浅性、肌层浸润性和转移性移行细胞癌:利用基因表达谱的cDNA阵列分析
Clin Cancer Res. 2004 May 15;10(10):3410-21. doi: 10.1158/1078-0432.CCR-03-0134.
4
Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression.癌症中大片染色体区域的基因表达改变包括多个与恶性进展无关的基因。
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8715-20. doi: 10.1073/pnas.0400027101. Epub 2004 May 20.
5
Clustering of molecular alterations in gastroesophageal carcinomas.胃食管癌分子改变的聚类分析
Neoplasia. 2004 Mar-Apr;6(2):143-9. doi: 10.1593/neo.03385.
6
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer.CDC91L1(PIG-U)是人类膀胱癌中一种新发现的致癌基因。
Nat Med. 2004 Apr;10(4):374-81. doi: 10.1038/nm1010. Epub 2004 Mar 14.
7
Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays.用于在少量重复微阵列中鉴定差异表达基因的局部合并误差检验。
Bioinformatics. 2003 Oct 12;19(15):1945-51. doi: 10.1093/bioinformatics/btg264.
8
Gene discovery in bladder cancer progression using cDNA microarrays.利用cDNA微阵列技术进行膀胱癌进展过程中的基因发现。
Am J Pathol. 2003 Aug;163(2):505-16. doi: 10.1016/S0002-9440(10)63679-6.
9
Identifying distinct classes of bladder carcinoma using microarrays.使用微阵列鉴定膀胱癌的不同类别。
Nat Genet. 2003 Jan;33(1):90-6. doi: 10.1038/ng1061. Epub 2002 Dec 9.
10
A molecular signature of metastasis in primary solid tumors.原发性实体瘤转移的分子特征。
Nat Genet. 2003 Jan;33(1):49-54. doi: 10.1038/ng1060. Epub 2002 Dec 9.

一种用于绘制人类膀胱癌转移能力基因表达图谱的新方法。

A novel method for gene expression mapping of metastatic competence in human bladder cancer.

作者信息

Wu Z, Siadaty M S, Riddick G, Frierson H F, Lee J K, Golden W, Knuutila S, Hampton G M, El-Rifai W, Theodorescu D

机构信息

Department of Molecular Physiology, Box 422, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.

出版信息

Neoplasia. 2006 Mar;8(3):181-9. doi: 10.1593/neo.05727.

DOI:10.1593/neo.05727
PMID:16611411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1578518/
Abstract

Expression profiling by DNA microarray analysis has provided insights into molecular alterations that underpin cancer progression and metastasis. Although differential expression of microarray-defined probes can be related to numerical or structural chromosomal alterations, it is unclear if such changes are also clustered in distinct chromosomes or genomic regions and whether chromosomal alterations always reflect changes in gene expression. Here we apply the dChip algorithm and a novel technique to test the hypothesis that expression changes occurring as a function of tumor progression and metastasis are nonrandomly distributed. Expression profiling of a human xenograft model of lung metastasis phenotype indicates that chromosomes 2, 11, and 20 contain higher percentages of differentially expressed genes (P < .05). Furthermore, we show that a number of differentially expressed probes mapped to chromosome 17q, defining the existence of an expression "hot spot" corresponding to an area of gain determined by comparative genomic hybridization (CGH). Interestingly, other areas of gains detected by CGH were not associated with expression hot spots. In summary, we show that gene expression changes during bladder cancer lung metastasis occur nonrandomly in specific chromosomes and intrachromosomal locations.

摘要

通过DNA微阵列分析进行的表达谱分析为深入了解支撑癌症进展和转移的分子改变提供了线索。尽管微阵列定义探针的差异表达可能与染色体的数量或结构改变有关,但尚不清楚这些变化是否也聚集在不同的染色体或基因组区域,以及染色体改变是否总是反映基因表达的变化。在此,我们应用dChip算法和一种新技术来检验这样一个假设,即随着肿瘤进展和转移而发生的表达变化是非随机分布的。对具有肺转移表型的人异种移植模型进行表达谱分析表明,2号、11号和20号染色体含有较高比例的差异表达基因(P < 0.05)。此外,我们发现许多差异表达探针定位于17q染色体,这确定了一个与通过比较基因组杂交(CGH)确定的增益区域相对应的表达“热点”的存在。有趣的是,CGH检测到的其他增益区域与表达热点无关。总之,我们表明膀胱癌肺转移过程中的基因表达变化在特定染色体和染色体内位置非随机发生。